Top Markets
#1 TENDIES TENDIES +53.31%
#2 Threshold Network Threshold Network +43.82%
#3 Mubarak Mubarak +31.56%
#4 Akedo Akedo +23.59%
#5 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#6 OSK OSK +16.18%
#7 MultiversX MultiversX +13.97%
#8 Ape and Pepe Ape and Pepe +12.62%
#9 Cash Cat Cash Cat +12.62%
#10 Kite Kite +11.90%
Coin of the day
TENDIES TENDIES
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
Rang in Aktien #17537
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Aktienkurs
$0.8033
Marktkapitalisierung
$236.66M
Veränderung (1 Tag)
-8.71%
Veränderung (1 Jahr)
-22.01%
Land
US
Handel Invivyd, Inc. (IVVD)

Kategorie

Healthcare
P/B-Verhältnis für Invivyd, Inc. (IVVD)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Invivyd, Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Invivyd, Inc. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.828 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.5116 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 3.9942 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 8.2199 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH